From HIV to COVID-19, Molecular Mechanisms of Pathogens' Trade-off and Persistence in the Community, Potential Targets for New Drug Development

Background: On the staggering emergence of the Omicron variant, numerous questions arose about the evolution of virulence and transmissibility in microbes.

Main Body Of The Abstract: The trade-off hypothesis has long speculated the exchange of virulence for the sake of superior transmissibility in a wide array of pathogens. While this certainly applies to the case of the Omicron variant, along with influenza virus, various reports have been allocated for an array of pathogens such as human immunodeficiency virus (HIV), malaria, hepatitis B virus (HBV) and tuberculosis (TB). The latter abide to another form of trade-off, the invasion-persistence trade-off. In this study, we aim to explore the molecular mechanisms and mutations of different obligate intracellular pathogens that attenuated their more morbid characters, virulence in acute infections and invasion in chronic infections.

Short Conclusion: Recognizing the mutations that attenuate the most morbid characters of pathogens such as virulence or persistence can help in tailoring new therapies for such pathogens. Targeting macrophage tropism of HIV by carbohydrate-binding agents, or targeting the TMPRSS2 receptors to prevent pulmonary infiltrates of COVID-19 is an example of how important is to recognize such genetic mechanisms.

References

Mok S, Stokes B, Gnadig N, Ross L, Yeo T, Amaratunga C . Artemisinin-resistant K13 mutations rewire Plasmodium falciparum's intra-erythrocytic metabolic program to enhance survival. Nat Commun. 2021; 12(1):530. PMC: 7822823. DOI: 10.1038/s41467-020-20805-w. View

Shapira T, Monreal I, Dion S, Buchholz D, Imbiakha B, Olmstead A . A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature. 2022; 605(7909):340-348. PMC: 9095466. DOI: 10.1038/s41586-022-04661-w. View

Dartois V, Rubin E . Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat Rev Microbiol. 2022; 20(11):685-701. PMC: 9045034. DOI: 10.1038/s41579-022-00731-y. View

Zheng H, Abramovitch R . Inhibiting DosRST as a new approach to tuberculosis therapy. Future Med Chem. 2020; 12(5):457-467. PMC: 7607383. DOI: 10.4155/fmc-2019-0263. View

Balestra A, Zeeshan M, Rea E, Pasquarello C, Brusini L, Mourier T . A divergent cyclin/cyclin-dependent kinase complex controls the atypical replication of a malaria parasite during gametogony and transmission. Elife. 2020; 9. PMC: 7308089. DOI: 10.7554/eLife.56474. View

Salimi Alizei E, Hofmann M, Thimme R, Neumann-Haefelin C . Mutational escape from cellular immunity in viral hepatitis: variations on a theme. Curr Opin Virol. 2021; 50:110-118. DOI: 10.1016/j.coviro.2021.08.002. View

Goldhill D, Turner P . The evolution of life history trade-offs in viruses. Curr Opin Virol. 2014; 8:79-84. DOI: 10.1016/j.coviro.2014.07.005. View

Alizon S, Hurford A, Mideo N, van Baalen M . Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. J Evol Biol. 2009; 22(2):245-59. DOI: 10.1111/j.1420-9101.2008.01658.x. View

Colagrossi L, Hermans L, Salpini R, Di Carlo D, Pas S, Alvarez M . Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC Infect Dis. 2018; 18(1):251. PMC: 5984771. DOI: 10.1186/s12879-018-3161-2. View

10.

Tumpey T, Maines T, Van Hoeven N, Glaser L, Solorzano A, Pappas C . A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science. 2007; 315(5812):655-9. DOI: 10.1126/science.1136212. View

11.

McKay B, Ebell M, Dale A, Shen Y, Handel A . Virulence-mediated infectiousness and activity trade-offs and their impact on transmission potential of influenza patients. Proc Biol Sci. 2020; 287(1927):20200496. PMC: 7287351. DOI: 10.1098/rspb.2020.0496. View

12.

Dorna J, Kaufmann A, Bockmann V, Raifer H, West J, Matrosovich M . Effects of Receptor Specificity and Conformational Stability of Influenza A Virus Hemagglutinin on Infection and Activation of Different Cell Types in Human PBMCs. Front Immunol. 2022; 13:827760. PMC: 8963867. DOI: 10.3389/fimmu.2022.827760. View

13.

Fantini J, Yahi N, Colson P, Chahinian H, La Scola B, Raoult D . The puzzling mutational landscape of the SARS-2-variant Omicron. J Med Virol. 2022; 94(5):2019-2025. PMC: 9015223. DOI: 10.1002/jmv.27577. View

14.

Wei C, Shan K, Wang W, Zhang S, Huan Q, Qian W . Evidence for a mouse origin of the SARS-CoV-2 Omicron variant. J Genet Genomics. 2021; 48(12):1111-1121. PMC: 8702434. DOI: 10.1016/j.jgg.2021.12.003. View

15.

Tizzano B, Dallenga T, Utpatel C, Behrends J, Homolka S, Kohl T . Survival of hypoxia-induced dormancy is not a common feature of all strains of the Mycobacterium tuberculosis complex. Sci Rep. 2021; 11(1):2628. PMC: 7846770. DOI: 10.1038/s41598-021-81223-6. View

16.

Singanayagam A, Hakki S, Dunning J, Madon K, Crone M, Koycheva A . Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2021; 22(2):183-195. PMC: 8554486. DOI: 10.1016/S1473-3099(21)00648-4. View

17.

Burki T . Herd immunity for COVID-19. Lancet Respir Med. 2020; 9(2):135-136. PMC: 7832483. DOI: 10.1016/S2213-2600(20)30555-5. View

18.

Kumar S, Thambiraja T, Karuppanan K, Subramaniam G . Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J Med Virol. 2021; 94(4):1641-1649. DOI: 10.1002/jmv.27526. View

19.

Zoulim F, Locarnini S . Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 2009; 137(5):1593-608.e1-2. DOI: 10.1053/j.gastro.2009.08.063. View

20.

Batyrshina Y, Schwartz Y . Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures. Tuberculosis (Edinb). 2019; 117:7-17. DOI: 10.1016/j.tube.2019.05.005. View